Treatment strategies in patients with Metastatic Breast Cancer: real-world practice in the United Kingdom (UK) and Italy

被引：0
|
作者：
Ferrari, L. [1 ]
Gerratana, L. [1 ]
Jove, M. [2 ]
Bonotto, M. [1 ]
Cinausero, M. [1 ]
Iacono, D. [1 ]
Fontanella, C. [1 ]
Bozza, C. [1 ]
Fanotto, V. [1 ]
Basile, D. [1 ]
Pelizzari, G. [1 ]
Vitale, M. G. [1 ]
Minisini, A. [1 ]
Mansutti, M. [1 ]
Russo, S. [1 ]
Andreetta, C. [1 ]
Fasola, G. [1 ]
Puglisi, F. [1 ]
Twelves, C. [2 ]
机构：
[1] Univ Hosp Udine, Dept Oncol, Udine, Italy
[2] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw337.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
F15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ASSESSING THE REAL-WORLD COST OF CARE IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (MTNBC) IN THE UNITED STATES
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    VALUE IN HEALTH, 2018, 21 : S36 - S36
  • [32] Real-world clinical effectiveness of eribulin in metastatic breast cancer patients with visceral metastases in the United States.
    Mougalian, Sarah Schellhorn
    Zhang, Jingchuan
    Kish, Jonathan
    Zettler, Marjorie E.
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States
    Mougalian, S. S.
    Kish, J. K.
    Zhang, J.
    Miller, T.
    Liassou, D.
    Laney, J.
    Iyer, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S369 - S369
  • [34] Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes
    Hackert, Mariska Q. N.
    Uden-Kraan, Cornelia F. van
    Agterof, Mariette J.
    Velden, Annette W. G. van der
    Vriens, Birgit E. P. J.
    Janssen, Johan J. B.
    Geenen, Maud
    van der Padt-pruijsten, Annemieke
    Van de Garde, Ewoudt M. W.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 35
  • [35] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [36] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [37] Real-world data on overall and progression-free survival for patients (pts) with metastatic colorectal cancer (mCRC) for the United Kingdom (UK) cohort of the PROMETCO study (PROMETCO-UK)
    Marti, F. E. Marti
    Raman, R.
    Brady, D.
    Walker, G.
    Dewdney, A.
    Lau, S. C.
    Agarwal, R.
    Bridgewater, J. A.
    Lo, N.
    McLeod, D.
    Chauvet, M-A.
    ANNALS OF ONCOLOGY, 2024, 35 : S48 - S48
  • [38] Real-world treatment patterns among metastatic breast cancer patients by BRCA status and phenotype.
    Sebby, Wendy
    Liede, Alexander
    Mazumder, Debasish
    Ghosh, Anirban
    Papademetriou, Eros
    Potluri, Ravi C.
    Bach, Bruce Allen
    Tyczynski, Jerzy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
    Skinner, Karen E.
    Walker, Mark S.
    Haiderali, Amin
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer
    Wang, Biyun
    Li, Yumeng
    Zhao, Yannan
    Sang, Die
    Yuan, Peng
    Zhao, Yanxia
    Lv, Zheng
    Xie, Ning
    Li, Nanling
    Li, Juanjuan
    Wang, Fang
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
12345